polyquaternium-1

Established in 1983, SHANDONG SHEELIAN PHARMACEUTICAL CO., LTD manufactures and trades cardiovascular system drug actives, animal extracts, and prophylactic biological products under its own brand. The company offers CRO, CMO, and CDMO contract manufacturing with T/T payment, serving markets across North America, Latin America, Europe, Australasia, Asia, the Middle East, and Africa, and emphasizes internationally recognized approvals, delivery reliability, production capacity, responsiveness to buyers' specifications, and acceptance of small orders.